DLG4 and Alzheimer disease: Most of these previous studies used models of tau overexpression, often with mutations associated with inherited tauopathies, while tau seeding studies using insoluble AD-tau did not assess synaptic density5,10,12,98, with the exception of one study that reported reduced synaptophysin and PSD95 levels in WT mice injected with AD-tau99.